Please assess the completion status of the following clinical trial:

Trial Title: Osteoarthritis Shoulder Injection Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* An X-ray within a year with Radiographic evidence of OA~* 18 years of age or older~* Clinical diagnosis established due to symptoms that will include pain attributed to glenohumeral osteoarthritis, pain with range of motion, and/or functional limitations longer than 3 months.~Exclusion Criteria:~* Previous guided steroid injection of the glenohumeral joint within 3 months~* Previous diagnosis of inflammatory arthritis, rotator cuff tear, or immunocompromised~* Previous shoulder surgery~* Allergy to steroid or lidocaine~* A Kellgren and Lawrence classification of 1 or less on radiograph~* Non-English Speaking~* Inability to provide informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 20 mg Triamcinolone with 3cc of 1% Lidocaine (Type: ACTIVE_COMPARATOR): 20mg Triamcinolone with 3cc of 1% Lidocaine
- 40 mg Triamcinolone with 3cc of 1% Lidocaine (Type: ACTIVE_COMPARATOR): 40mg Triamcinolone with 3cc of 1% Lidocaine
- 80 mg Triamcinolone with 3cc of 1% Lidocaine (Type: ACTIVE_COMPARATOR): 80mg Triamcinolone with 3cc of 1% Lidocaine

Based on this trial design, predict the completion outcome and termination type (if applicable).